Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-27T16:35:08.903Z Has data issue: false hasContentIssue false
  • English
  • Français

Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitro

Published online by Cambridge University Press:  06 April 2009

W. E. Gutteridge  and
P. I. Trigg
W. E. Gutteridge
Affiliation:
National Institute for Medical Research, Mill Hill, London, N. W. 7
P. I. Trigg
Affiliation:
National Institute for Medical Research, Mill Hill, London, N. W. 7
Get access Rights & Permissions [Opens in a new window]

Extract

A dihydrofolate reductase has been isolated from free-parasite preparations of the primate malarial parasite, Plasmodium knowlesi. Its properties are similar to those reported for the enzyme from the rodent malarial parasite, P. berghei, even though the base compositions of the DNA of these two species are quite different. The Kms for substrate and cofactor are 3 × 10−6M and 1 × 10−6M respectively and the molecular weight is ˜ 200000. Concentrations of pyrimethamine and trimethoprim as low as 1 × 10−9M and 3 × 10−8M respectively are sufficient to cause 50% inhibition of enzyme activity. The sensitivity to inhibition by pyrimethamine and trimethoprim of growth of cultures of P. knowlesi has also been investigated. Preliminary experiments showed that it was only the schizont stage that was susceptible to the action of the drugs and that in their presence, normal nuclear divisions and segmentation did not occur and subsequently, no reinvasion of fresh red cells took place. The minimum concentrations of drug required to produce these effects were 10−9M for pyrimethamine and 10−7M for trimethoprim. Thus, there is a close correlation between the concentrations of pyrimethamine and trimethoprim required to inhibit the dihydrofolate reductase in a cell-free system and the growth of the parasite in vitro. Pyrimethamine (10−9M) did not, however, affect the incorporation of radioactive precursors into DNA, RNA or protein of schizont stage parasites until after morphological damage could be seen and reinvasion was complete in control cultures. The time courses of incorporation of [14C]algal protein hydrolysate into protein in the presence (10−9M) or absence of pyrimethamine are the same as those described recently with immune serum. The possibility is thus raised as to whether pyrimethamine and immune serum act in the same way.

One of us (P.I.T.) received financial assistance from the World Health Organization. We thank Dr F. Hawking for many helpful discussions, Miss Jane Dunnett and Mr T. Scott-Finnigan for technical assistance and Dr O. D. Standen for samples of pyrimethamine and trimethoprim.

Type
Research Article
Information
Parasitology , Volume 62 , Issue 3 , June 1971 , pp. 431 - 444
Copyright
Copyright © Cambridge University Press 1971

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Aikawa, M. & Beaudoin, R. L. (1968). Studies on nuclear division of a malarial parasite under pyrimethamine treatment. Journal of Cell Biology 39, 749–54.CrossRefGoogle ScholarPubMed
Andrews, P. (1965). The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochemical Journal 96, 595–606.CrossRefGoogle ScholarPubMed
Cohen, S., Butcher, G. A. & Crandall, R. B. (1969). Action of malarial antibody in vitro. Nature 223, 368–71.CrossRefGoogle ScholarPubMed
Ferone, R. (1970). Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei. Journal of Biological Chemistry 245, 850–4.CrossRefGoogle ScholarPubMed
Ferone, R., Burchall, J. J. & Hitchings, G. H. (1969). Plasmodium berghei dihydrofolate reductase. Isolation, properties and inhibition by antifolates. Molecular Pharmacology 5, 49–59.Google ScholarPubMed
Futterman, S. (1957). Enzymatic reduction of folic acid and dihydrofolic acid to tetrahydrofolic acid. Journal of Biological Chemistry 228, 1031–8.CrossRefGoogle ScholarPubMed
Gutteridge, W. E., Jaffe, J. J. & Mccormack, J. J. Jr (1969). The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids. Biochimica et biophysica acta 191, 753–5.CrossRefGoogle ScholarPubMed
Gutteridge, W. E., Mccormack, J. J. Jr & Jaffe, J. J. (1969). Presence and properties of dihydrofolate reductases within the genus Crithidia. Biochimica et biophysica acta 178, 453–8.CrossRefGoogle ScholarPubMed
Gutteridge, W. E. & Trigg, P. I. (1970 a). Some studies on the effects of dihydrofolate reductase inhibitors. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 12.Google Scholar
Gutteridge, W. E. & Trigg, P. I. (1970 b). Incorporation of radioactive precursors into DNA and RNA of Plasmodium knowlesi in vitro. Journal of Protozoology 17, 89–96.CrossRefGoogle ScholarPubMed
Gutteridge, W. E., Trigg, P. I. & Williamson, D. H. (1969). Base compositions of DNA from some malarial parasites. Nature 224, 1210–11.CrossRefGoogle ScholarPubMed
Gutteridge, W. E., Trigg, P. I. & Williamson, D. H. (1971). Properties of DNA from some malarial parasites. Parasitology 62, 209–19.CrossRefGoogle ScholarPubMed
Jaffe, J. J., Mccormack, J. J. Jr & Gutteridge, W. E. (1969). Comparative study of dihydrofolate reductases within the genus Trypanosoma. Experimental Parasitology 25, 311–18.CrossRefGoogle Scholar
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265–75.CrossRefGoogle ScholarPubMed
Mcgregor, I. A. & Smith, D. A. (1952). Daraprim in treatment of malaria. A study of its effects in falciparum and quartan infections in West Africa. British Medical Journal 1, 730–2.CrossRefGoogle ScholarPubMed
Perkins, J. P., Hillman, G., Fischer, D. & Bertino, J. R. (1969). Antibody to dihydrofolate reductase from a methotrexate-resistant subline of the L1210 Lymphoma. Molecular Pharmacology 5, 213–18.Google ScholarPubMed
Polet, H. & Conrad, M. E. (1968). Malaria: extracellular amino acid requirements for in vitro growth of erythrocytic forms of Plasmodium knowlesi. Proceedings of the Society for Experimental Biology and Medicine 127, 251–3.CrossRefGoogle ScholarPubMed
Schellenberg, K. A. & Coatney, G. R. (1961). The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. Biochemical Pharmacology 6, 143–52.CrossRefGoogle ScholarPubMed
Trigg, P. I. (1968). A new continuous perfusion technique for the cultivation of malaria parasites in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 62, 371–8.CrossRefGoogle Scholar
Trigg, P. I. (1969 a). The use of proprietary tissue culture media for the cultivation in vitro of the erythrocytic stages of Plasmodium knowlesi. Parasitology 59, 925–35.CrossRefGoogle ScholarPubMed
Trigg, P. I. (1969 b). Some factors affecting the cultivation in vitro of the erythrocytic stages of Plasmodium knowlesi. Parasitology 59, 915–24.CrossRefGoogle ScholarPubMed
Trigg, P. I., Brown, I. N., Gutteridge, W. E., Hockley, D. J. & Williamson, J. (1970). The preparation of free malaria parasites by nitrogen cavitation. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 2–3.Google ScholarPubMed
Trigg, P. I. & Gutteridge, W. E. (1971). A minimal medium for the growth of Plasmodium knowlesi in dilution cultures. Parasitology 62, 113–23.CrossRefGoogle ScholarPubMed
Walsh, C. J. & Sherman, I. W. (1968). Purine and pyrimidine biosynthesis by the avian malaria parasite, Plasmodium lophurae. Journal of Protozoology 15, 763–70.CrossRefGoogle ScholarPubMed
Williamson, J. (1967). Antigens of Plasmodium knowlesi. Protozoology 2, 85–104.Google Scholar